Highland Capital Management (Texas) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vistra
VST
|
+$32.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Castle Biosciences
CSTL
|
+$62.7M |
| 2 |
AVYA
Avaya Holdings Corp. Common Stock
AVYA
|
+$12.7M |
| 3 |
ARCH
Arch Resources, Inc.
ARCH
|
+$12.5M |
| 4 |
Warrior Met Coal
HCC
|
+$1.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Utilities | 99.11% |
| 2 | Materials | 0.88% |
| 3 | Real Estate | 0.01% |
| 4 | Healthcare | 0% |
| 5 | Energy | 0% |
No holdings matched the selected filter criteria.
Similar funds
Highland Capital Management (Texas)'s Q2 2021 Portfolio in Review
As of Q2 2021, Highland Capital Management (Texas) held 7 positions worth $39M, down 70% from $129M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Highland Capital Management (Texas) withdrew a net $57.5M in Q2 2021, closing 4 positions and reducing 1 holding. Its most notable exit was Castle Biosciences, an estimated $62.7M position sold in full.
By sector, the portfolio is most concentrated in Utilities at 99% of assets, up from 30% a quarter earlier, followed by Materials and Real Estate.
Against the trend, Highland Capital Management (Texas) added an estimated $32.2M to Vistra.
- Highland Capital Management (Texas) added most to Vistra in Q2 2021, an estimated $32.2M increase.
- Highland Capital Management (Texas)'s biggest Q2 2021 reduction was Warrior Met Coal, cutting an estimated $1.8M.
- Highland Capital Management (Texas) fully exited Castle Biosciences in Q2 2021, selling an estimated $62.7M.
- Highland Capital Management (Texas)'s ten largest holdings make up 100% of its $39M portfolio in Q2 2021.
- Highland Capital Management (Texas) opened 0 new positions and closed 4 in Q2 2021.
- Highland Capital Management (Texas)'s portfolio value fell 70% quarter-over-quarter to $39M.
Based on Highland Capital Management (Texas)'s 13F filing for Q2 2021, filed 16 Aug 2021.